FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 151 filers reported holding FIVE PRIME THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 1.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $149,000 | +122.4% | 3,958 | 0.0% | 0.00% | – |
| Q4 2020 | $67,000 | +103.0% | 3,958 | -43.5% | 0.00% | – |
| Q3 2020 | $33,000 | -23.3% | 7,002 | 0.0% | 0.00% | – |
| Q2 2020 | $43,000 | +168.8% | 7,002 | 0.0% | 0.00% | – |
| Q1 2020 | $16,000 | -50.0% | 7,002 | 0.0% | 0.00% | – |
| Q4 2019 | $32,000 | +18.5% | 7,002 | 0.0% | 0.00% | – |
| Q3 2019 | $27,000 | -35.7% | 7,002 | 0.0% | 0.00% | – |
| Q2 2019 | $42,000 | -55.3% | 7,002 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $94,000 | +44.6% | 7,002 | 0.0% | 0.00% | – |
| Q4 2018 | $65,000 | -33.0% | 7,002 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $97,000 | +148.7% | 7,002 | +180.6% | 0.00% | – |
| Q2 2018 | $39,000 | -9.3% | 2,495 | 0.0% | 0.00% | – |
| Q1 2018 | $43,000 | -21.8% | 2,495 | 0.0% | 0.00% | – |
| Q4 2017 | $55,000 | – | 2,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|